TFF Pharmaceuticals rakes in $8.17 mln
TFF Pharmaceuticals Inc, an early-stage biopharmaceutical company focused on treating chronic respiratory diseases and lung conditions, has secured $8.17 million in funding. The investors were not named.
30 May 2019•1 min read
